Can a Rapid-Acting clot blocker boost stroke recovery?

NCT ID NCT07760922

Not yet recruiting Disease control Sponsor: Xinqiao Hospital of Chongqing Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial investigates whether adding tirofiban, a fast-acting anti-clotting drug, to standard aspirin treatment can improve recovery in people who have had a moderate ischemic stroke. Participants receive either tirofiban or a placebo, both with aspirin, within 24 hours of stroke onset. The study measures how many people achieve a good functional outcome at 90 days, while also monitoring for bleeding complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tirofiban (a blood-clotting blocker) given intravenously, combined with aspirin
What this could lead to: If it works, this could offer a new treatment option to improve functional recovery and reduce disability after moderate ischemic stroke.
What could go wrong: The trial is still testing the approach, and there is a risk of bleeding in the brain, a serious side effect. Results may not confirm a clear benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE, ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE, ACUTE

Contacts and locations

Locations

The First Affiliated Hospital of Gannan Medical University

Nanchang, Jiangxi, 341000, China
The First Affiliated Hospital of Hainan Medical University

Haikou, Hainan, 570000, China
The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, 341000, China
The First People's Hospital of Jingdezhen City

Jingdezhen, Jiangxi, 341000, China
The First People's Hospital of Jiujiang City

Jiujiang, Jiangxi, 341000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.